NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). […]
US LABOR SEP NONFARM PAYROLLS +254K; CONSENSUS +150K US SEP UNEMPLOYMENT RATE 4.1%; CONSENSUS 4.2% US SEP AVERAGE HOURLY EARNINGS +0.37%, OR +$0.13 TO $35.36; […]